Trobiani, C.; Ubaldi, N.; Teodoli, L.; Tipaldi, M.A.; Cappelli, F.; Ungania, S.; Vallati, G.
The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study. J. Pers. Med. 2024, 14, 511.
https://doi.org/10.3390/jpm14050511
AMA Style
Trobiani C, Ubaldi N, Teodoli L, Tipaldi MA, Cappelli F, Ungania S, Vallati G.
The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study. Journal of Personalized Medicine. 2024; 14(5):511.
https://doi.org/10.3390/jpm14050511
Chicago/Turabian Style
Trobiani, Claudio, Nicolò Ubaldi, Leonardo Teodoli, Marcello Andrea Tipaldi, Federico Cappelli, Sara Ungania, and Giulio Vallati.
2024. "The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study" Journal of Personalized Medicine 14, no. 5: 511.
https://doi.org/10.3390/jpm14050511
APA Style
Trobiani, C., Ubaldi, N., Teodoli, L., Tipaldi, M. A., Cappelli, F., Ungania, S., & Vallati, G.
(2024). The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study. Journal of Personalized Medicine, 14(5), 511.
https://doi.org/10.3390/jpm14050511
